With H1 performance supporting its unchanged 2026 guidance, the company enters the second half with continued momentum across nutrition, health and beauty markets.
In South Asia, aflatoxins were detected in 85% of samples, marking a 30% increase from the previous year.
The new office will strengthen dsm-firmenich’s regional innovation, customer collaboration, and technical support capabilities.
The center is expected to strengthen the Netherlands’ position as a hub for food and biotech innovation.
To achieve this milestone, dsm-firmenich implemented a sourcing strategy aligned with the technical criteria of RE100.